ArticleBMC public health2026
Delayed mammography screening and advanced breast cancer: variation across age and income groups.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundRegular screening mammography can detect breast cancer at an earlier stage, leading to better outcomes, including significantly improved survival rates and quality of life. However, the association between delayed mammography and the likelihood of advanced-stage breast cancer remains unclear.
methodsThis population-based case-case study used Taiwan's National Health Insurance Research Database linked to the Cancer Registry to examine the association between delayed mammography and advanced-stage breast cancer. Subjects with stages 0-II breast cancer were classified as early-stage, while those with stages III-IV were classified as advanced-stage breast cancer. The main exposure was time since last screening mammogram prior to cancer diagnosis. Multivariable logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for advanced cancer, adjusting for demographic and clinical factors.
results11,672 were diagnosed with early-stage breast cancer, and 2,220 with advanced-stage breast cancer. Compared with patients who had undergone mammography screening, those who had never undergone screening had higher odds of being diagnosed with advanced-stage breast cancer (aOR = 1.94, 95% CI = 1.73-2.16). Compared with women with more recent mammography, those with screening intervals of more than two years (aOR = 1.42, 95% CI = 1.18-1.70) and more than four years (aOR = 1.38, 95% CI = 1.13-1.68) had higher odds of advanced-stage breast cancer. Age-specific analyses showed that delaying mammography over four years was associated with higher odds of advanced-stage breast cancer in women aged 40-69, those 70 and older, and in low-income groups.
conclusionsDelayed mammography screening is associated with higher odds of advanced-stage breast cancer at diagnosis, particularly among women aged 40 and older and those in low-income groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.